Literature DB >> 12214787

Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors.

J Leserman1, J M Petitto, H Gu, B N Gaynes, J Barroso, R N Golden, D O Perkins, J D Folds, D L Evans.   

Abstract

BACKGROUND: The primary aim of this study is to examine prospectively the association of stressful life events, social support, depressive symptoms, anger, serum cortisol and lymphocyte subsets with changes in multiple measures of human immunodeficiency virus (HIV) disease progression.
METHODS: Ninety-six HIV-infected gay men without symptoms or anti-retroviral medication use at baseline were studied every 6 months for up to 9 years. Disease progression was defined in three ways using the Centers for Disease Control (CDC) classifications (e.g. AIDS, clinical AIDS condition and mortality). Cox regression models with time-dependent covariates were used, adjusting for control variables (e.g. race, age, baseline, CD4 T cells and viral load, number of anti-retroviral medications).
RESULTS: Higher cumulative average stressful life events and lower cumulative average social support predicted faster progression to both the CDC AIDS classification and a clinical AIDS condition. Higher anger scores and CD8 T cells were associated with faster progression to AIDS, and depressive symptoms were associated with faster development of an AIDS clinical condition. Higher levels of serum cortisol predicted all three measures of disease progression.
CONCLUSIONS: These results suggest that stressful life events, dysphoric mood and limited social support are associated with more rapid clinical progression in HIV infection, with serum cortisol also exerting an independent effect on disease progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12214787     DOI: 10.1017/s0033291702005949

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  104 in total

1.  The HIV Epidemic Among Individuals with Mental Illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

Review 2.  The HIV epidemic among individuals with mental illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

Review 3.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

4.  Reduced telomerase activity in human T lymphocytes exposed to cortisol.

Authors:  Jenny Choi; Steven R Fauce; Rita B Effros
Journal:  Brain Behav Immun       Date:  2008-01-25       Impact factor: 7.217

5.  Personality and serotonin transporter genotype interact with social context to affect immunity and viral set-point in simian immunodeficiency virus disease.

Authors:  John P Capitanio; Kristina Abel; Sally P Mendoza; Shelley A Blozis; Michael B McChesney; Steve W Cole; William A Mason
Journal:  Brain Behav Immun       Date:  2007-08-23       Impact factor: 7.217

6.  The Role of Chronic Psychosocial Stress in Explaining Racial Differences in Stress Reactivity and Pain Sensitivity.

Authors:  Jennifer L Gordon; Jacqueline Johnson; Samantha Nau; Beth Mechlin; Susan S Girdler
Journal:  Psychosom Med       Date:  2017 Feb/Mar       Impact factor: 4.312

7.  How have long-term survivors coped with living with HIV?

Authors:  Jacquelyn Slomka; Jung-won Lim; Barbara Gripshover; Barbara Daly
Journal:  J Assoc Nurses AIDS Care       Date:  2012-12-17       Impact factor: 1.354

8.  The interaction of mindful-based attention and awareness and disengagement coping with HIV/AIDS-related stigma in regard to concurrent anxiety and depressive symptoms among adults with HIV/AIDS.

Authors:  Adam Gonzalez; Sondra E Solomon; Michael J Zvolensky; Carol T Miller
Journal:  J Health Psychol       Date:  2009-04

9.  Does the occurrence of adverse life events in patients with breast cancer lead to a change in illness behaviour?

Authors:  Siegfried Geyer; Dorothee Noeres; Mariya Mollova; Heike Sassmann; Alexandra Prochnow; Mechthild Neises
Journal:  Support Care Cancer       Date:  2008-07-29       Impact factor: 3.603

10.  Gender-specific effects of an augmented written emotional disclosure intervention on posttraumatic, depressive, and HIV-disease-related outcomes: a randomized, controlled trial.

Authors:  Gail Ironson; Conall O'Cleirigh; Jane Leserman; Rick Stuetzle; Joanne Fordiani; MaryAnn Fletcher; Neil Schneiderman
Journal:  J Consult Clin Psychol       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.